Published in N Engl J Med on August 10, 1972
Clonal proliferation of PHA-stimulated human lymphocytes in soft agar culture. Immunology (1975) 2.98
Hodgkin's disease. An immunodepleting and immunosuppressive disorder. J Clin Invest (1975) 2.44
Expression of myeloid differentiation antigens on normal and malignant myeloid cells. J Clin Invest (1981) 2.34
The Sézary syndrome: a malignant proliferation of helper T cells. J Clin Invest (1976) 2.32
A unique cell surface antigen identifying lymphoid malignancies of B cell origin. J Clin Invest (1981) 1.93
New approaches to the classification of the lymphomata. Br J Cancer Suppl (1975) 1.88
Immunoglobulin and glucose-6-phosphate dehydrogenase as markers of cellular origin in Burkitt lymphoma. J Exp Med (1973) 1.42
Human lymphocyte surface immunoglobulin capping. Normal characteristics and anomalous behavior of chronic lymphocytic leukemic lymphocytes. J Clin Invest (1975) 1.26
Expression of immunoglobin G on blood lymphocytes in chronic lymphocytic leukaemia. Clin Exp Immunol (1978) 1.26
Ultrastructural, immunologic, and functional studies on Sézary cells: a neoplastic variant of thymus-derived (T) lymphocytes. Proc Natl Acad Sci U S A (1974) 1.24
B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease. J Clin Invest (1973) 1.17
T and B lymphocytes in multiple sclerosis. Clin Exp Immunol (1975) 1.09
Evaluation of T and B lymphocyte membrane markers in human non-Hodgkin malignant lymphomata. Br J Cancer Suppl (1975) 1.06
Recovery of immunoglobulin removed from lymphocytic surfaces by proteolysis. Immunology (1974) 1.04
Mechanisms of lymphocyte activation: the role of suppressor cells in the proliferative responses of chronic lymphatic leukemia lymphocytes. J Clin Invest (1979) 1.03
T gamma (T gamma) cells suppress growth of erythroid colony-forming units in vitro in the pure red cell aplasia of B-cell chronic lymphocytic leukemia. J Clin Invest (1982) 1.02
Studies on the distribution of surface immunoglobulins of human B-lymphocytes. J Clin Invest (1973) 1.01
T and B cell populations in blood and lymph node in lymphoproliferative disease. Br J Cancer (1975) 1.00
Tissue culture studies in Hodgkin's disease: Morphologic, cytogenetic, cell surface, and enzymatic properties of cultures derived from splenic tumors. J Exp Med (1977) 0.99
Electrophoresis of lymphocytes from normal human subjects and patients with chronic lymphocytic leukaemia. Clin Exp Immunol (1974) 0.99
Separation of T lymphocytes from normal individuals and patients with B lymphocyte chronic lymphocytic leukaemia. Immunology (1975) 0.97
Surface receptors on human haematopoietic cell lines. Clin Exp Immunol (1976) 0.95
The association of alpha2-macroglobulin with lymphocyte membranes in chronic lymphocytic leukaemia and other disorders. Clin Exp Immunol (1975) 0.94
Idiotypic uniformity of cell surface immunoglobulin in chronic lymphocytic leukeima. Evidence for monoclonal proliferation. J Exp Med (1974) 0.93
T and B lymphocytes in humans. A review. Am J Pathol (1975) 0.91
Morphology of lymphatic cells and of their derived tumours. J Clin Pathol (1978) 0.90
Standardization of diagnostic materials. 4. Diagnostic immunofluorescence. Bull World Health Organ (1973) 0.90
Differences in the formation of normal T lymphocyte colonies by peripheral blood cells from patients with chronic lymphocytic leukemia and Hodgkin's disease. Clin Exp Immunol (1979) 0.88
B-cell markers on lymphoblasts in acute lymphoblastic leukaemia. Clin Exp Immunol (1974) 0.88
Surface immunoglobulins in chronic lymphatic leukaemia, macroglobulinaemia and myelomatosis. Clin Exp Immunol (1974) 0.88
Evidence for a change in the expression of beta2-microglobulin-assoicated membrane structures on leukaemic human cells. Clin Exp Immunol (1978) 0.87
Unusual human lymphoma phenotype defined by monoclonal antibody. J Exp Med (1980) 0.86
Partial characterization of the shift from IgG to IgA synthesis in the clonal differentiation of human leukemic bone marrow-derived lymphocytes. J Exp Med (1975) 0.86
Alterations in the distribution and proliferative responses of rhesus monkey peripheral blood and spleen cells during malaria (Plasmodium knowlesi) infection. Infect Immun (1980) 0.86
Combined T and B cell acute lymphoblastic leukaemia. Br Med J (1974) 0.86
Extension of the mean time to death of mice with a lethal infection of Venezuelan equine encephalomyelitis virus by antithymocyte serum treatment. Infect Immun (1975) 0.85
Rheumatoid knee synovitis successfully treated with intra-articular rifamycin SV. Ann Rheum Dis (1982) 0.85
Blood lymphocytes in chronic lymphocytic leukaemia and Hodgkin's disease: Immunological features and enzymes of nucleoside metabolism. Clin Exp Immunol (1977) 0.84
T-cell and B-cell identification in the diagnosis of lymphoproliferative disease. A review. Am J Pathol (1977) 0.84
Membrane-bound immunoglobulins on human leukemic cells. Evidence for humoral immune responses of patients to leukemia-associated antigens. J Clin Invest (1975) 0.83
Antigenic analysis of the lymphomata. Br J Cancer Suppl (1975) 0.83
Membrane-associated immunoglobulins of human lymphocytes in immunologic disorders. Clin Exp Immunol (1973) 0.81
Peripheral blood B-lymphocyte abnormalities associated with hyperthyroidism of Graves' disease. Clin Exp Immunol (1976) 0.81
Quantitative analysis of neutral glycosphingolipids from human lymphocyte subpopulations. Biochem J (1980) 0.80
Receptors for immunoglobulin isotype on T and B lymphocytes from untreated patients with chronic lymphocytic leukaemia. Clin Exp Immunol (1980) 0.80
Chronic lymphocytic leukemia cells lack the 185,000-dalton macromolecular insoluble cold globulin present on normal B lymphocytes. J Clin Invest (1981) 0.79
Spontaneous lymphocyte transformation in chronic lymphocytic leukaemia. Clin Exp Immunol (1977) 0.78
Functional and phenotypic heterogeneity of electrophoretically separated leukaemic B cells from patients with chronic lymphocytic leukaemia. Clin Exp Immunol (1985) 0.78
Inhibition of normal lymphocyte transformation by plasma and lymphocyte factors in chronic lymphatic leukaemia. Clin Exp Immunol (1974) 0.78
Giant-cell tumour of bone: cytological studies. Br J Cancer (1979) 0.78
IgD-Fc receptors on normal and neoplastic human B lymphocytes. Clin Exp Immunol (1982) 0.75
Acute lymphoblastic leukaemia of the B-cell type refractory to intensive chemotherapy. Clin Exp Immunol (1978) 0.75
Tumours of the lymphoreticular system: nomenclature, histogenesis, and behaviour. J Clin Pathol Suppl (R Coll Pathol) (1974) 0.75
Lymphocyte subpopulations and surface membrane immunoglobulins in myasthenia gravis. J Neurol Neurosurg Psychiatry (1982) 0.75
Structure and biological functions of human IgD. XII. Anti-IgD enhancement of PHA responsiveness in patients with chronic lymphocytic leukaemia. Clin Exp Immunol (1977) 0.75
Correlation between serum IgG-2 concentrations and the antibody response to bacterial polysaccharide antigens. N Engl J Med (1980) 3.95
Antibodies involved in antigen-induced release of slow reacting substance of anaphylaxis (SRS-A) in the guinea pig and rat. J Exp Med (1967) 3.08
Intestinal uptake of macromolecules: effect of oral immunization. Science (1972) 2.80
The anaphylactic antibodies of mammals including man. Prog Allergy (1967) 2.38
Studies on cyclophosphamide-induced tolerance to sheep erythrocytes. J Exp Med (1967) 2.19
Defining the smallest analyte concentration an immunoassay can measure. Clin Chem (1996) 2.18
Increased susceptibility to infection in a patient with type II essential hypercatabolism of C3. N Engl J Med (1973) 2.17
Immunologic relationship between blood group substances and a fucose-containing glycolipid of human adenocarcinoma. J Immunol (1967) 1.88
Hapten-specific IgE antibody responses in mice. I. Secondary IgE responses in irradiated recipients of syngeneic primed spleen cells. J Exp Med (1973) 1.87
Impaired antibody response to pneumococcal vaccine after treatment for Hodgkin's disease. N Engl J Med (1978) 1.86
Heterogeneity in biologic functions of antibodies: implications for immunologic tumor enhancement. Fed Proc (1966) 1.72
Manifestations of immunologic unresponsiveness in Hodgkin's disease. Cancer Res (1966) 1.71
Immunological tolerance induced by cyclophosphamide assayed by plaque spleen cell method. Nature (1967) 1.69
Antinuclear factors in synovia. Possible participants in the rheumatoid inclusion body. JAMA (1966) 1.67
IgE and IgGa antibody-mediated release of histamine from rat peritoneal cells. I. Optimum conditions for in vitro preparation of target cells with antibody and and challenge with antigen. J Exp Med (1971) 1.64
Cell-surface immunoglobulins in chronic lymphocytic leukemia and allied disorders. Am J Med (1973) 1.61
Homocytotropic antibody response in the rat infected with the nematode, Nippostrongylus brasiliensis. II. Characteristics of the immune response. J Immunol (1968) 1.59
The zymogen of tadpole collagenase. Biochemistry (1971) 1.56
Inhibition of human skin collagenase by human serum. J Lab Clin Med (1970) 1.53
Intestinal uptake of macromolecules. II. Effect of parenteral immunization. J Immunol (1973) 1.53
Biologic properties of rat antibodies. I. Antigen-binding by four classes of anti-DNP antibodies. J Immunol (1968) 1.50
Biologic properties of rat antibodies. 3. Histamine release mediated by two classes of antibodies. J Immunol (1969) 1.49
Intestinal uptake of macromolecules. III. Studies on the mechanism by which immunization interferes with antigen uptake. J Immunol (1975) 1.49
Anaphylaxis during induction of general anesthesia: subsequent evaluation and management. J Allergy Clin Immunol (1990) 1.46
Immunoconglutinin in various rheumatic diseases and certain diseases suspected of an autoimmune pathogenesis. Arthritis Rheum (1967) 1.43
The thymus and recovery of the sheep erythrocyte response in irradiated mice. J Exp Med (1968) 1.42
Potentiated reagin response: initiation with minute doses of antigen and alum followed by infection with Nippostrongylus brasiliensis. J Immunol (1973) 1.38
Lymphocyte surface characteristics in malignant lymphoma. Am J Med (1975) 1.36
Some characteristics of human immunoconglutinin. J Immunol (1966) 1.36
The thymus and recovery from cyclophosphamide-induced tolerance to sheep erythrocytes. J Exp Med (1968) 1.35
Stimulation by immune complexes of mucus release from goblet cells of the rat small intestine. Science (1977) 1.35
Serological Reactivity of Synthetic Polyglucoses. Proc Natl Acad Sci U S A (1953) 1.32
Antibodies to type III and type VIII pneumococcal polysaccharides: evidence for restricted structural heterogeneity in hyperimmunized rabbits. J Immunol (1970) 1.30
Intestinal goblet cell mucus release. II. In vivo stimulation by antigen in the immunized rat. J Immunol (1979) 1.29
Rearrangement of the gene for the beta chain of the T-cell receptor in T-cell chronic lymphocytic leukemia and related disorders. N Engl J Med (1985) 1.27
Allogeneic thymus grafts and the restoration of immune function in irradiated thymectomized mice. J Exp Med (1970) 1.27
Biosynthetic defect in monocytes from human beings with genetic deficiency of the second component of complement. N Engl J Med (1975) 1.27
Mediastinal large cell lymphoma. An uncommon subset of adult lymphoma curable with combined modality therapy. Cancer (1988) 1.26
Homocytotropic antibody response in the rat infected with the nematode, Nippostrongylus brasiliensis. 3. Characteristics of the antibody. J Immunol (1968) 1.23
The lubricating activity of human synovial fluids. Arthritis Rheum (1984) 1.22
Properties of structurally restricted antibody to type VIII pneumococcal polysaccharide. J Immunol (1970) 1.17
An evaluation of antibodies and clinical resistance to salmon calcitonin. J Clin Invest (1972) 1.16
Impaired humoral immunity in treated Hodgkin's disease. N Engl J Med (1977) 1.15
A comparative study of four methods for detecting fibrinogen degradation products in patients with various diseases. N Engl J Med (1970) 1.14
Cell surface phenotype in lymphoproliferative disease. Am J Med (1980) 1.13
Anaphylactic release of intestinal goblet cell mucus. Immunology (1980) 1.12
Effect of locally induced intestinal anaphylaxis on the uptake of a bystander antigen. J Allergy Clin Immunol (1981) 1.12
Heavy-chain disease. Report of a seventh case. N Engl J Med (1968) 1.10
A tumor antigen in tissue cultures derived from patients with Hodgkin's disease. Proc Natl Acad Sci U S A (1973) 1.09
Protein Hal: partial deletion of a " " immunoglobulin gene(s) and apparent reinitiation at an internal AUG codon. Proc Natl Acad Sci U S A (1973) 1.09
An antigen in Hodgkin's disease tissue cultures: fluorescent antibody studies. Proc Natl Acad Sci U S A (1974) 1.09
Anti-heat shock protein 70 antibodies in Meniere's disease. Laryngoscope (2000) 1.09
Current concepts in immunology: Cell-surface markers in lymphoproliferative disease. N Engl J Med (1981) 1.08
Effect of disodium cromoglycate on certain passive cutaneous anaphylactic reactions. J Immunol (1969) 1.07
Lymphosarcoma cell leukemia: the contribution of cell surface study to diagnosis. Blood (1976) 1.06
Inhaled nitric oxide. A bronchodilator in mild asthmatics with methacholine-induced bronchospasm. Am J Respir Crit Care Med (1996) 1.04
Lymphedema, lymphocytic myocarditis, and sarcoidlike granulomatosis. Manifestations of Whipple's disease. JAMA (1989) 1.04
Malignant lymphoma with dual B and T cell markers. Analysis of the neoplastic cells with monoclonal antibodies directed against T cell subsets. J Exp Med (1981) 1.04
The staging and treatment of Hodgkin's disease. N Engl J Med (1978) 1.03
Primary large cell lymphoma of the mediastinum. A histologic and immunophenotypic study of 29 cases. Am J Surg Pathol (1989) 1.03
Mechanisms of immunologic injury of rat peritoneal mast cells. 3. Cytotoxic histamine release. J Immunol (1967) 1.02
Ocular anaphylaxis induced in the rat by topical application of compound 48/80. Dose response and time course study. Acta Ophthalmol Suppl (1989) 1.01
Monoclonal antibody studies in non-Hodgkin's lymphoma. Blood (1983) 1.01
Intestinal uptake of macromolecules. IV.--The effect of pancreatic duct ligation on the breakdown of antigen and antigen-antibody complexes on the intestinal surface. Gastroenterology (1975) 1.01
Incidence of antibody to EB virus, herpes simplex, and cytomegalovirus in Hodgkin's disease. Cancer (1970) 1.01
Reaction of normal human lymphocytes and chronic lymphocytic leukemia cells with an antithymocyte antiserum. Blood (1973) 1.00
Combination chemotherapy of Hodgkin's disease. Cancer (1974) 1.00
Intestinal uptake of macromolecules. VI. Uptake of protein antigen in vivo in normal rats and in rats infected with Nippostrongylus brasiliensis or subjected to mild systemic anaphylaxis. Gastroenterology (1979) 1.00
Hyperviscosity syndromes associated with immunoglobulin abnormalities. Semin Hematol (1973) 1.00
Distribution of peripheral blood latex-ingesting cells, T cells, and B cells in patients with myasthenia gravis. Ann N Y Acad Sci (1976) 1.00
An antigen in Hodgkin's disease tissue cultures: radioiodine-labeled antibody studies. Proc Natl Acad Sci U S A (1974) 0.99
Tissue culture studies in Hodgkin's disease: Morphologic, cytogenetic, cell surface, and enzymatic properties of cultures derived from splenic tumors. J Exp Med (1977) 0.99
Improved survival in hodgkin's disease. Cancer (1976) 0.99
Fibrinopeptide A in plasma of normal subjects and patients with disseminated intravascular coagulation and systemic lupus erythematosus. J Clin Invest (1976) 0.99
Primary non-Hodgkin's lymphoma of the mediastinum. Cancer (1982) 0.98
Variation in the primary structure of antibodies during the course of immunization. Biochemistry (1971) 0.98
Essential mixed cryoglobulinemia without evidence for hepatitis B virus infection. Ann Intern Med (1980) 0.98
Chronic lymphocytic leukemia cells: rosette formation and adherence to nylon fiber columns. J Natl Cancer Inst (1974) 0.98
The relationship between antigenic complexity and heterogeneity in the antibody response. Biochemistry (1969) 0.97
Allergens of mammalian origin. III. Properties of a major feline allergen. J Immunol (1974) 0.97
The natural history of nodular lymphoma. Cancer (1976) 0.96
Rapid oral challenge-desensitization for patients with aspirin-related urticaria-angioedema. J Allergy Clin Immunol (2000) 0.96
Humoral hypercalcemia in Hodgkin's disease. Clinical and laboratory evaluation. Cancer (1989) 0.96
Failure to obtain histamine release from rat mast cells exposed to human allergic serum and specific antigen or IgE myeloma protein and anti-IgE. J Immunol (1973) 0.95
Chronic T-cell lymphocytosis with neutropenia: report of a case studied with monoclonal antibody. Blood (1981) 0.95
Human and rat gamma E: serologic evidence of homology. J Immunol (1971) 0.95
Acute eosinophilic hepatitis from trovafloxacin. N Engl J Med (2000) 0.95
Transformation by simian virus 40 of spleen cells from a hyperimmune rabbit: evidence for synthesis of immunoglobulin by the transformed cells. Proc Natl Acad Sci U S A (1974) 0.95
Sjögren's syndrome. A clinical, pathological, and serological study of sixty-two cases. 1965. Medicine (Baltimore) (1992) 0.94
Multiple myeloma associated with two serum M components, gamma-G type K and gamma-A type L. N Engl J Med (1967) 0.94
The influence of ultraviolet radiation on allergic contact dermatitis in the guinea-pig. I. UVB radiation. Br J Dermatol (1981) 0.94
Binding of exogenous protein fragments to native proteins: possible explanation for the overestimation of uptake of extrinsically labelled macromolecules from the gut. Immunology (1981) 0.94
Serum antibodies against heat shock protein 70 in Menière's disease. Am J Otol (1995) 0.94
Diffuse large cell (histiocytic) lymphoma of the spleen. Clinical and pathologic characteristics of ten cases. Cancer (1984) 0.93
Lymph node T cells in Hodgkin's disease: analysis of suspensions with monoclonal antibody and rosetting techniques. Blood (1982) 0.93